Enovis ROA 2012-2025 | ENOV
Current and historical return on assets (ROA) values for Enovis (ENOV) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Enovis ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $-1.37B | $4.43B | -28.71% |
| 2025-06-30 | $-0.83B | $5.02B | -16.42% |
| 2025-03-31 | $-0.81B | $4.88B | -15.74% |
| 2024-12-31 | $-0.83B | $4.72B | -15.59% |
| 2024-09-30 | $-0.12B | $5.55B | -2.29% |
| 2024-06-30 | $-0.09B | $5.44B | -1.84% |
| 2024-03-31 | $-0.08B | $5.48B | -1.74% |
| 2023-12-31 | $-0.03B | $4.51B | -0.75% |
| 2023-09-30 | $-0.08B | $4.40B | -1.72% |
| 2023-06-30 | $-0.14B | $4.44B | -3.18% |
| 2023-03-31 | $-0.05B | $4.30B | -1.19% |
| 2022-12-31 | $-0.01B | $4.27B | -0.26% |
| 2022-09-30 | $0.02B | $4.45B | 0.35% |
| 2022-06-30 | $0.12B | $4.50B | 1.57% |
| 2022-03-31 | $0.07B | $8.48B | 0.84% |
| 2021-12-31 | $0.07B | $8.52B | 0.90% |
| 2021-09-30 | $0.11B | $7.97B | 1.38% |
| 2021-06-30 | $0.09B | $7.56B | 1.25% |
| 2021-03-31 | $0.06B | $8.07B | 0.77% |
| 2020-12-31 | $0.04B | $7.35B | 0.58% |
| 2020-09-30 | $-0.01B | $7.15B | -0.11% |
| 2020-06-30 | $-0.01B | $7.12B | -0.14% |
| 2020-03-31 | $-0.47B | $7.46B | -5.50% |
| 2019-12-31 | $-0.53B | $7.39B | -5.65% |
| 2019-09-30 | $-0.47B | $9.59B | -5.08% |
| 2019-06-30 | $-0.44B | $9.90B | -5.31% |
| 2019-03-31 | $0.06B | $10.50B | 0.84% |
| 2018-12-31 | $0.14B | $6.62B | 2.12% |
| 2018-09-30 | $0.11B | $6.45B | 1.62% |
| 2018-06-30 | $0.12B | $6.46B | 1.81% |
| 2018-03-31 | $0.14B | $6.88B | 2.02% |
| 2017-12-31 | $0.15B | $6.71B | 2.26% |
| 2017-09-30 | $0.18B | $6.84B | 2.67% |
| 2017-06-30 | $0.16B | $6.73B | 2.43% |
| 2017-03-31 | $0.15B | $6.43B | 2.24% |
| 2016-12-31 | $0.13B | $6.34B | 1.97% |
| 2016-09-30 | $0.14B | $6.54B | 2.03% |
| 2016-06-30 | $0.13B | $6.58B | 1.85% |
| 2016-03-31 | $0.14B | $6.72B | 2.01% |
| 2015-12-31 | $0.17B | $6.73B | 2.41% |
| 2015-09-30 | $0.20B | $7.04B | 2.88% |
| 2015-06-30 | $0.26B | $7.01B | 3.60% |
| 2015-03-31 | $0.40B | $6.95B | 5.36% |
| 2014-12-31 | $0.37B | $7.21B | 5.03% |
| 2014-09-30 | $0.33B | $7.53B | 4.51% |
| 2014-06-30 | $0.30B | $7.93B | 4.37% |
| 2014-03-31 | $0.16B | $6.77B | 2.53% |
| 2013-12-31 | $0.16B | $6.60B | 2.54% |
| 2013-09-30 | $0.14B | $6.33B | 2.26% |
| 2013-06-30 | $0.09B | $6.09B | 1.52% |
| 2013-03-31 | $0.05B | $5.85B | 0.76% |
| 2012-12-31 | $-0.08B | $6.15B | -1.36% |
| 2012-09-30 | $-0.11B | $6.06B | -2.37% |
| 2012-06-30 | $-0.11B | $6.01B | -3.20% |
| 2012-03-31 | $-0.11B | $6.13B | -4.76% |
| 2011-12-31 | $0.01B | $1.09B | 0.47% |
| 2011-09-30 | $0.03B | $1.04B | 2.87% |
| 2011-06-30 | $0.03B | $1.06B | 3.08% |
| 2011-03-31 | $0.02B | $1.06B | 2.37% |
| 2010-12-31 | $0.02B | $1.02B | 1.71% |
| 2010-09-30 | $0.02B | $1.00B | 1.51% |
| 2010-06-30 | $0.02B | $0.97B | 1.51% |
| 2010-03-31 | $0.02B | $0.99B | 1.73% |
| 2009-12-31 | $0.02B | $1.01B | 2.51% |
| 2009-09-30 | $0.03B | $1.03B | 3.01% |
| 2009-06-30 | $0.04B | $0.90B | 3.95% |
| 2009-03-31 | $0.00B | $0.89B | -0.33% |
| 2008-12-31 | $0.00B | $0.91B | -0.32% |
| 2008-09-30 | $-0.01B | $0.94B | -1.19% |
| 2008-06-30 | $0.00B | $0.94B | 0.00% |
| 2008-03-31 | $0.04B | $0.91B | 8.83% |
| 2007-12-31 | $0.04B | $0.90B | 17.39% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.245B | $2.108B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $28.621B | 33.10 |
| Tempus AI (TEM) | United States | $9.242B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $4.646B | 0.00 |
| Doximity (DOCS) | United States | $4.621B | 20.02 |
| Hims & Hers Health (HIMS) | United States | $3.711B | 30.18 |
| Hinge Health (HNGE) | United States | $3.065B | 0.00 |
| Privia Health (PRVA) | United States | $2.754B | 172.23 |
| 10x Genomics (TXG) | United States | $2.293B | 0.00 |
| Heartflow (HTFL) | United States | $1.759B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.736B | 23.16 |
| Omnicell (OMCL) | United States | $1.638B | 45.62 |
| Azenta (AZTA) | United States | $1.318B | 53.00 |
| Clover Health Investments (CLOV) | United States | $1.044B | 0.00 |
| Schrodinger (SDGR) | United States | $0.840B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.768B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.724B | 0.00 |
| Phreesia (PHR) | United States | $0.720B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Standard BioTools (LAB) | United States | $0.431B | 0.00 |
| Claritev (CTEV) | United States | $0.380B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.338B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.320B | 0.00 |
| Evolent Health (EVH) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.307B | 0.00 |
| TruBridge (TBRG) | United States | $0.293B | 13.45 |
| Carlsmed (CARL) | United States | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.216B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.161B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.160B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.151B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.130B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 5.40 |
| American Well (AMWL) | United States | $0.088B | 0.00 |
| 111 (YI) | China | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.064B | 0.00 |
| Outset Medical (OM) | United States | $0.062B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Precipio (PRPO) | United States | $0.041B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.032B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.017B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| Movano (MOVE) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.005B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |